Beyond Blind Biopsy: Hysteroscopy as Standard of Care

Plain-Language Summary
This editorial argues against relying on blind endometrial biopsy or D&C to detect malignancies. It emphasizes hysteroscopy as the new gold standard for evaluating abnormal uterine bleeding and endometrial pathology.

Key Takeaways:

• Blind biopsy often misses focal lesions and cancers.

• Hysteroscopy allows direct visualization and targeted biopsy.

• Clinical guidelines increasingly recognize hysteroscopy as superior to D&C.

Citation:
Loffer FD. The Time Has Come to Quit Relying on a Blind Endometrial Biopsy or Dilation and Curettage to Rule Out Malignant Endometrial Changes. J Minim Invasive Gynecol. 2019;26(7):1208–1213. doi:10.1016/j.jmig.2019.04.011